Transaction #9719 · Form 4 · 0001559834-25-000006
Xtant Medical Holdings, Inc. · Stock award · Common Stock
Xtant Medical Holdings, Inc. · Transacted November 15, 2025 · Filed November 18, 2025
What does this filing report?
An SEC Form 4 filing for Xtant Medical Holdings, Inc. records a stock award involving Common Stock on November 15, 2025. The reported quantity was 553,797. The filing date is November 18, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Xtant Medical Holdings, Inc.
- Company CIK
- 0001453593
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 553,797
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 7,515,570
- Ownership description
- Not reported
- SEC acceptance time
- Nov 18, 2025, 5:34 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Vizirgianakis Stavros G. ↗
Director
CIK 0001559834
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
- F2
- Includes 1,520,215 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.